ADiTx Therapeutics ADTX

$ 0.19 -15.93%

Quarterly report 2024-Q3
added 11-18-2024

ADiTx Therapeutics Balance Sheet 2011-2024 | ADTX

Annual Balance Sheet ADiTx Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	1.94 M	203 K	-	-8.66 M	162 K	47.9 K	-25 K	-	-	-	-	-	-
Long Term Debt	1.04 M	1.89 M	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	1 M	1.09 M	-	391 K	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	858 K	-	-	25 K	-	-	-	-	-	-
Total Current Liabilities	25.9 M	3.64 M	3.61 M	1.23 M	-	-	-	-	-	-	-	-	-
Total Liabilities	28.5 M	5.53 M	6.48 M	2.09 M	2.98 M	1.65 M	84.9 K	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-128 M	-95 M	-67.4 M	-20.9 M	-11.7 M	-5.9 M	-213 K	-	-	-	-	-	-
Total Assets	44.6 M	10.7 M	16.7 M	13.1 M	124 K	116 K	25 K	-	-	-	-	-	-
Cash and Cash Equivalents	97.1 K	2.77 M	7.87 M	10.5 M	4.09 K	-	-	-	-	-	-	-	-
Book Value	16 M	5.21 M	10.2 M	11 M	-2.85 M	-1.54 M	-59.9 K	-	-	-	-	-	-
Total Shareholders Equity	16.1 M	5.21 M	10.2 M	11 M	-2.85 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet ADiTx Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	592 K	745 K	892 K	1.04 M	1.2 M	1.42 M	-	1.89 M	-	-	-	5	2.77 M	2.96 M	779 K	858 K	865 K	858 K	858 K	-	-	-	-	-	-	-	35 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	25.4 M	22 M	18.2 M	28.5 M	12.4 M	11.2 M	7.57 M	5.53 M	6.49 M	9.38 M	7.07 M	6.48 M	6.61 M	9.94 M	6.65 M	2.09 M	2.09 M	2.09 M	2.09 M	2.98 M	2.98 M	2.98 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-163 M	-150 M	-142 M	-128 M	-117 M	-107 M	-101 M	-95 M	-86.8 M	-79.3 M	-73.4 M	-67.4 M	-43.3 M	-33.4 M	-27.3 M	-20.9 M	-20.9 M	-20.9 M	-20.9 M	-11.7 M	-11.7 M	-11.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	29.8 M	28.4 M	28 M	44.6 M	8.23 M	7.29 M	7.63 M	10.7 M	19.2 M	10.7 M	11.8 M	16.7 M	19.6 M	15.9 M	18 M	13.1 M	13.1 M	13.1 M	13.1 M	124 K	124 K	124 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	329 K	91.2 K	88.7 K	97.1 K	1.65 M	96 K	303 K	2.77 M	9.24 M	804 K	2.12 M	7.87 M	5.47 M	8.61 M	14 M	10.5 M	10.5 M	10.5 M	10.5 M	4.09 K	4.09 K	4.09 K	-	116 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	4.45 M	6.34 M	9.78 M	16 M	-4.22 M	-3.87 M	68.1 K	5.21 M	12.7 M	1.36 M	4.72 M	10.2 M	13 M	5.96 M	11.4 M	11 M	11 M	11 M	11 M	-2.85 M	-2.85 M	-2.85 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	4.71 M	6.57 M	9.93 M	16.1 M	-4.22 M	-3.87 M	68.1 K	5.21 M	12.7 M	1.36 M	4.72 M	10.2 M	13 M	5.96 M	11.4 M	11 M	11 M	11 M	11 M	-2.85 M	-2.85 M	-2.85 M	-1.81 M	-1.54 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency